ULS reported Q4 2025 revenue of USD 789 million (+6.8%), including 5.7% organic growth, and net income of USD 71 million (−16.5%) reflecting a USD 37 million pre-tax restructuring charge. Q4 diluted EPS was USD 0.32 (−20.0%), while adjusted diluted EPS was USD 0.53 (+8.2%). Adjusted EBITDA in Q4 was USD 217 million (+28.4%), with adjusted EBITDA margin of 27.5% (up 460 basis points). For FY 2025, ULS posted revenue of USD 3.05 billion (+6.4%), including 6.2% organic growth, and net income of USD 345 million (unchanged), including a USD 35 million pre-tax restructuring charge. FY diluted EPS was USD 1.60 (−1.2%), and adjusted diluted EPS was USD 1.99 (+17.1%). FY adjusted EBITDA was USD 792 million (+20.7%), with adjusted EBITDA margin of 25.9% (up 300 basis points), and net cash flows provided by operating activities reached a record USD 600 million. Management said results exceeded guidance, highlighted demand across all geographic regions and operational initiatives such as laboratory productivity gains and footprint optimization, and introduced a 2026 outlook calling for mid-single digit constant currency organic revenue growth and continued adjusted EBITDA margin improvement. The company also announced an increase in its quarterly dividend.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UL Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001901440-26-000003), on February 19, 2026, and is solely responsible for the information contained therein.